Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Amneal's Q2 2024 injectable product launches:
Product launch | Dosage form | ASHP drug shortage | |
1 | PEMRYDI RTU® | Vial | No |
2 | Atropine sulfate | Prefilled syringe | Yes |
3 | Docetaxel | Injection | Yes |
4 | Foscarnet | IV bag | No |
5 | Methylprednisolone acetate | Multi-dose vial | Yes |
6 | Calcium gluconate | Vial | No |
Posted In: AMRX